291 related articles for article (PubMed ID: 16254337)
1. The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors.
Tan M; Jiang X
J Virol; 2005 Nov; 79(22):14017-30. PubMed ID: 16254337
[TBL] [Abstract][Full Text] [Related]
2. The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors.
Tan M; Hegde RS; Jiang X
J Virol; 2004 Jun; 78(12):6233-42. PubMed ID: 15163716
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping of histo blood group antigens bound to norovirus VLPs using STD NMR experiments reveals fine details of molecular recognition.
Fiege B; Leuthold M; Parra F; Dalton KP; Meloncelli PJ; Lowary TL; Peters T
Glycoconj J; 2017 Oct; 34(5):679-689. PubMed ID: 28823097
[TBL] [Abstract][Full Text] [Related]
4. Human noroviruses' fondness for histo-blood group antigens.
Singh BK; Leuthold MM; Hansman GS
J Virol; 2015 Feb; 89(4):2024-40. PubMed ID: 25428879
[TBL] [Abstract][Full Text] [Related]
5. Affinities of human histo-blood group antigens for norovirus capsid protein complexes.
Han L; Kitova EN; Tan M; Jiang X; Pluvinage B; Boraston AB; Klassen JS
Glycobiology; 2015 Feb; 25(2):170-80. PubMed ID: 25395406
[TBL] [Abstract][Full Text] [Related]
6. Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study.
Tan M; Xia M; Cao S; Huang P; Farkas T; Meller J; Hegde RS; Li X; Rao Z; Jiang X
Virology; 2008 Sep; 379(2):324-34. PubMed ID: 18692213
[TBL] [Abstract][Full Text] [Related]
7. Noroviral P particle: structure, function and applications in virus-host interaction.
Tan M; Fang P; Chachiyo T; Xia M; Huang P; Fang Z; Jiang W; Jiang X
Virology; 2008 Dec; 382(1):115-23. PubMed ID: 18926552
[TBL] [Abstract][Full Text] [Related]
8. C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein.
Tan M; Meller J; Jiang X
J Virol; 2006 Aug; 80(15):7322-31. PubMed ID: 16840313
[TBL] [Abstract][Full Text] [Related]
9. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution.
Shanker S; Choi JM; Sankaran B; Atmar RL; Estes MK; Prasad BV
J Virol; 2011 Sep; 85(17):8635-45. PubMed ID: 21715503
[TBL] [Abstract][Full Text] [Related]
11. Structural analysis of a rabbit hemorrhagic disease virus binding to histo-blood group antigens.
Leuthold MM; Dalton KP; Hansman GS
J Virol; 2015 Feb; 89(4):2378-87. PubMed ID: 25505081
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability.
Hansman GS; Biertümpfel C; Georgiev I; McLellan JS; Chen L; Zhou T; Katayama K; Kwong PD
J Virol; 2011 Jul; 85(13):6687-701. PubMed ID: 21525337
[TBL] [Abstract][Full Text] [Related]
13. Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket.
Tan M; Huang P; Meller J; Zhong W; Farkas T; Jiang X
J Virol; 2003 Dec; 77(23):12562-71. PubMed ID: 14610179
[TBL] [Abstract][Full Text] [Related]
14. Quasispecies dynamics and molecular evolution of human norovirus capsid P region during chronic infection.
Carlsson B; Lindberg AM; Rodriguez-Díaz J; Hedlund KO; Persson B; Svensson L
J Gen Virol; 2009 Feb; 90(Pt 2):432-441. PubMed ID: 19141453
[TBL] [Abstract][Full Text] [Related]
15. Structural Basis for Human Norovirus Capsid Binding to Bile Acids.
Kilic T; Koromyslova A; Hansman GS
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355683
[TBL] [Abstract][Full Text] [Related]
16. Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens.
Ali ES; Rajapaksha H; Carr JM; Petrovsky N
Antiviral Res; 2016 Sep; 133():14-22. PubMed ID: 27421712
[TBL] [Abstract][Full Text] [Related]
17. Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization.
Koromyslova AD; Hansman GS
PLoS Pathog; 2017 Nov; 13(11):e1006636. PubMed ID: 29095961
[TBL] [Abstract][Full Text] [Related]
18. A post-translational modification of human Norovirus capsid protein attenuates glycan binding.
Mallagaray A; Creutznacher R; Dülfer J; Mayer PHO; Grimm LL; Orduña JM; Trabjerg E; Stehle T; Rand KD; Blaum BS; Uetrecht C; Peters T
Nat Commun; 2019 Mar; 10(1):1320. PubMed ID: 30899001
[TBL] [Abstract][Full Text] [Related]
19. Structural Basis of Nanobodies Targeting the Prototype Norovirus.
Ruoff K; Kilic T; Devant J; Koromyslova A; Ringel A; Hempelmann A; Geiss C; Graf J; Haas M; Roggenbach I; Hansman G
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602609
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis and homology modeling of capsid protein of norovirus GII.14.
Chan-It W; Thongprachum A; Okitsu S; Mizuguchi M; Ushijima H
J Med Virol; 2014 Feb; 86(2):329-34. PubMed ID: 24009213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
